BR112022004036A2 - Comprimido mastigável palatável - Google Patents

Comprimido mastigável palatável

Info

Publication number
BR112022004036A2
BR112022004036A2 BR112022004036A BR112022004036A BR112022004036A2 BR 112022004036 A2 BR112022004036 A2 BR 112022004036A2 BR 112022004036 A BR112022004036 A BR 112022004036A BR 112022004036 A BR112022004036 A BR 112022004036A BR 112022004036 A2 BR112022004036 A2 BR 112022004036A2
Authority
BR
Brazil
Prior art keywords
palatable
chewable tablet
animal
present
palatable chewable
Prior art date
Application number
BR112022004036A
Other languages
English (en)
Inventor
Stacy Ross
Original Assignee
Elanco Us Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elanco Us Inc filed Critical Elanco Us Inc
Publication of BR112022004036A2 publication Critical patent/BR112022004036A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

comprimido mastigável palatável. a presente invenção se refere a uma composição de mastigação macia palatável compreendendo pelo menos um agente ativo, pelo menos um agente umectante e pelo menos um palatante ou aromatizante. a presente invenção também fornece métodos para controlar ou tratar uma condição em um animal compreendendo a administração da composição palatável a um animal em necessidade da mesma.
BR112022004036A 2019-09-06 2020-09-04 Comprimido mastigável palatável BR112022004036A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962897094P 2019-09-06 2019-09-06
PCT/US2020/049327 WO2021046296A1 (en) 2019-09-06 2020-09-04 Palatable soft-chew

Publications (1)

Publication Number Publication Date
BR112022004036A2 true BR112022004036A2 (pt) 2022-05-24

Family

ID=74849879

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022004036A BR112022004036A2 (pt) 2019-09-06 2020-09-04 Comprimido mastigável palatável

Country Status (9)

Country Link
US (1) US20210069104A1 (pt)
EP (1) EP4025209A4 (pt)
JP (1) JP2022546241A (pt)
CN (1) CN114929215A (pt)
AU (1) AU2020342991A1 (pt)
BR (1) BR112022004036A2 (pt)
CA (1) CA3153622A1 (pt)
TW (1) TW202122077A (pt)
WO (1) WO2021046296A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115671288B (zh) * 2021-07-21 2024-05-10 瑞普（天津）生物药业有限公司 一种抗寄生虫复方软咀嚼药物制剂及其制备方法与应用
WO2023198476A1 (en) * 2022-04-15 2023-10-19 Krka, D.D., Novo Mesto Soft chewable veterinary dosage form
WO2023220930A1 (en) * 2022-05-17 2023-11-23 Increvet, Inc. Veterinary pharmaceutical formulations cross-references to related applications
FR3138315A1 (fr) 2022-07-27 2024-02-02 Virbac Produit à usage vétérinaire et procédé pour sa fabrication

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
TWI366442B (en) * 2003-07-30 2012-06-21 Novartis Ag Palatable ductile chewable veterinary composition
CN103200930A (zh) * 2010-10-12 2013-07-10 拜耳知识产权有限责任公司 非淀粉基软咀嚼品
EP3215120A1 (en) * 2014-11-03 2017-09-13 Zoetis Services LLC Palatable chewable veterinary composition
US9808010B2 (en) * 2015-07-06 2017-11-07 Virbac Corporation Chewable composition
US20220409547A1 (en) * 2015-12-19 2022-12-29 First Time Us Generics Llc Soft-Chew Tablet Pharmaceutical Formulations
CN105963270B (zh) * 2016-06-30 2019-01-15 齐鲁动物保健品有限公司 一种盐酸贝那普利软咀嚼片及其制备方法
CN109418576A (zh) * 2017-08-24 2019-03-05 盖树永 一种适口性好的诱食型猪饲料
CN109497306A (zh) * 2018-10-29 2019-03-22 安徽绿迪食品股份有限公司 一种野猪仔猪用营养适口性好饲料
CN113438941A (zh) * 2019-02-20 2021-09-24 硕腾服务有限责任公司 可口制剂
WO2020234898A1 (en) * 2019-05-21 2020-11-26 Cuckos Pharmaceutical Private Limited Process for manufacturing soft chewable free flowing granules and companion animal products thereof

Also Published As

Publication number Publication date
WO2021046296A1 (en) 2021-03-11
CA3153622A1 (en) 2021-03-11
CN114929215A (zh) 2022-08-19
EP4025209A1 (en) 2022-07-13
EP4025209A4 (en) 2023-09-13
JP2022546241A (ja) 2022-11-04
TW202122077A (zh) 2021-06-16
AU2020342991A1 (en) 2022-04-21
US20210069104A1 (en) 2021-03-11

Similar Documents

Publication Publication Date Title
BR112022004036A2 (pt) Comprimido mastigável palatável
MX2017005721A (es) Composicion veterinaria masticable agradable al paladar.
BR112014019262A8 (pt) Composições orais veterinárias parasíticas compreendendo ingredientes ativos de ação sistêmica, métodos e uso das mesmas
BR112018075998A2 (pt) composições antifúngicas sinérgicas e métodos das mesmas
BR112017021073A2 (pt) composições injetáveis de liberação prolongada compreendendo um agente ativo de isoxazolina, seus métodos e usos
AR058679A1 (es) Preparacion farmaceutica que contiene meloxicam
BR112017027811A2 (pt) conjugados específicos de inibidores de ksp
BR112013008834A2 (pt) produtos mastigáveis macios não à base de amido
ECSP056074A (es) Composiciones y método para tratar las infecciones microbianas y parasitarias en el ganado y otros animales
MY197171A (en) Compounds and methods for the treatment of parasitic diseases
BR112017028468A2 (pt) formulação sólida oral, e método para preparar uma formulação sólida oral
BR112022018645A2 (pt) Composições e métodos para tratar ou prevenir doenças inflamatórias, incluindo diabetes mellitus tipo i e tipo ii e doenças da tireoide
BRPI0916885B8 (pt) composição farmacêutica
BR112019003136A2 (pt) forma de dosagem multiunitária de composição farmacêutica, forma de dosagem unitária de composição farmacêutica, forma de dosagem multiunitária / unitária, kit e método de tratamento de uma condição tratável por administração oral de um agente terapeuticamente ativo
MX2021002606A (es) Formulaciones antiparasitarias agradables al paladar.
IL284930A (en) History of pyrrolopyrimidines and their use in the treatment of protein kinase-related diseases
ECSP22040921A (es) Composición farmacéutica que comprende selexipag
NZ701697A (en) Stable veterinary anthelmintic formulations
CR20150508A (es) Formulaciones veterinarias estables de combinación de lactonas macrocíclicas e imidazotiazoles
MX2020006055A (es) Composiciones farmaceuticas implantables de isoxazolina y usos de las mismas.
AR118150A1 (es) Método no terapéutico para la modulación dirigida de la expresión génica de al menos un receptor de sabor amargo y/o al menos un receptor del eje de intestino-cerebro, en rumiantes y/o cerdos; y producto para usar con el mismo
BR112022004038A2 (pt) Composições veterinárias granulares palatáveis
BR112023006143A2 (pt) Composição farmacêutica para prevenir ou tratar doença hepática colestática, contendo beta-lapachona como ingrediente ativo
BR112012024346A2 (pt) agente terapêutico ou agente profilático para a doença de alzheimer
BR112017016078A2 (pt) composições e métodos para uso crônico de um composto de ganho de peso

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A ANUIDADE.

B08G Application fees: restoration [chapter 8.7 patent gazette]